Published in Nature on November 26, 2009
Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol (2012) 3.48
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat Mater (2011) 2.71
Key roles of adjuvants in modern vaccines. Nat Med (2013) 2.62
Engineering nano- and microparticles to tune immunity. Adv Mater (2012) 1.75
Structure-based programming of lymph-node targeting in molecular vaccines. Nature (2014) 1.60
Nanoparticle-detained toxins for safe and effective vaccination. Nat Nanotechnol (2013) 1.50
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci U S A (2011) 1.39
Biomimetic delivery with micro- and nanoparticles. Adv Mater (2012) 1.25
pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides. ACS Nano (2013) 1.13
Twenty-first century challenges for biomaterials. J R Soc Interface (2010) 1.10
Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J Virol (2010) 1.00
Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope. Biomaterials (2012) 0.99
Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles. PLoS One (2013) 0.98
Long-circulating 15 nm micelles based on amphiphilic 3-helix peptide-PEG conjugates. ACS Nano (2012) 0.96
Nanoscale artificial antigen presenting cells for T cell immunotherapy. Nanomedicine (2013) 0.95
Strategies to reduce dendritic cell activation through functional biomaterial design. Biomaterials (2012) 0.91
Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes. Hum Vaccin (2011) 0.89
Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses. J Control Release (2014) 0.88
Beyond antigens and adjuvants: formulating future vaccines. J Clin Invest (2016) 0.87
Protein bio-corona: critical issue in immune nanotoxicology. Arch Toxicol (2016) 0.87
Hydrogels to modulate lentivirus delivery in vivo from microporous tissue engineering scaffolds. Drug Deliv Transl Res (2011) 0.87
Inflammatory cytokines presented from polymer matrices differentially generate and activate DCs in situ. Adv Funct Mater (2013) 0.87
The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine (Lond) (2015) 0.86
Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity. AAPS J (2014) 0.85
Rapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity. Mol Pharm (2015) 0.85
Metal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential Applications. Biomed Res Int (2015) 0.85
Repositioning Clofazimine as a Macrophage-Targeting Photoacoustic Contrast Agent. Sci Rep (2016) 0.84
Immunotherapy with injectable hydrogels to treat obstructive nephropathy. J Biomed Mater Res A (2013) 0.82
Hydrogels and scaffolds for immunomodulation. Adv Mater (2014) 0.82
pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation. Proc Natl Acad Sci U S A (2016) 0.82
L-Rhamnose-containing supramolecular nanofibrils as potential immunosuppressive materials. Org Biomol Chem (2014) 0.82
Relationship of vaccine efficacy to the kinetics of DC and T-cell responses induced by PLG-based cancer vaccines. Biomatter (2013) 0.82
Advancing biomaterials of human origin for tissue engineering. Prog Polym Sci (2015) 0.81
Modular Vaccine Design Using Carrier-Free Capsules Assembled from Polyionic Immune Signals. ACS Biomater Sci Eng (2015) 0.81
Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D. PLoS One (2013) 0.81
Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice. PLoS One (2012) 0.81
Engaging adaptive immunity with biomaterials. J Mater Chem B Mater Biol Med (2014) 0.81
A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8(+) T Cells. Sci Rep (2016) 0.81
Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery. Curr Opin Chem Eng (2015) 0.80
Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease. Clin Exp Vaccine Res (2015) 0.80
Mesoporous silicon microparticles enhance MHC class I cross-antigen presentation by human dendritic cells. Clin Dev Immunol (2013) 0.80
Induction of protective anti-CTL epitope responses against HER-2-positive breast cancer based on multivalent T7 phage nanoparticles. PLoS One (2012) 0.79
PEG-maleimide hydrogels for protein and cell delivery in regenerative medicine. Ann Biomed Eng (2013) 0.79
Distribution and Cellular Uptake of PEGylated Polymeric Particles in the Lung Towards Cell-Specific Targeted Delivery. Pharm Res (2015) 0.79
Enhancement of MHC-I antigen presentation via architectural control of pH-responsive, endosomolytic polymer nanoparticles. AAPS J (2014) 0.79
Targeted immunomodulation using antigen-conjugated nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2014) 0.79
Applications of nanomaterials as vaccine adjuvants. Hum Vaccin Immunother (2014) 0.79
Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance. Mol Ther (2017) 0.79
Pediatric Vaccine Adjuvants: Components of the Modern Vaccinologist's Toolbox. Pediatr Infect Dis J (2015) 0.78
Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV. Hum Vaccin Immunother (2013) 0.78
Micro and nanoparticle drug delivery systems for preventing allotransplant rejection. Clin Immunol (2015) 0.78
Enzymatic stability and immunoregulatory efficacy of a synthetic indolicidin analogue with regular enantiomeric sequence. ACS Med Chem Lett (2013) 0.78
Tailoring Nanostructure Morphology for Enhanced Targeting of Dendritic Cells in Atherosclerosis. ACS Nano (2016) 0.78
Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles. Int J Nanomedicine (2013) 0.77
Modulation of Immune Response Using Engineered Nanoparticle Surfaces. Small (2015) 0.77
Size-dependent effects of gold nanoparticles uptake on maturation and antitumor functions of human dendritic cells in vitro. PLoS One (2014) 0.77
Nanotoxoid Vaccines. Nano Today (2014) 0.77
Transgene expression and local tissue distribution of naked and polymer-condensed plasmid DNA after intradermal administration in mice. J Control Release (2012) 0.77
Intranasal administration of poly-gamma glutamate induced antiviral activity and protective immune responses against H1N1 influenza A virus infection. Virol J (2015) 0.77
Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy. Annu Rev Biomed Eng (2016) 0.77
Engineering an "infectious" T(reg) biomimetic through chemoselective tethering of TGF-β1 to PEG brush surfaces. Biomaterials (2015) 0.76
Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine. Hum Vaccin Immunother (2016) 0.76
Chemokine programming dendritic cell antigen response: part I - select chemokine programming of antigen uptake even after maturation. Immunology (2013) 0.76
Synergizing Engineering and Biology to Treat and Model Skeletal Muscle Injury and Disease. Annu Rev Biomed Eng (2015) 0.76
Towards programming immune tolerance through geometric manipulation of phosphatidylserine. Biomaterials (2015) 0.76
Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting. Vaccines (Basel) (2016) 0.76
Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis. Regen Eng Transl Med (2016) 0.76
T lymphocyte antigen 4-modified dendritic cell therapy for asthmatic mice guided by the CCR7 chemokine receptor. Int J Mol Sci (2014) 0.76
Surface Coating of Nanoparticles Reduces Background Inflammatory Activity while Increasing Particle Uptake and Delivery. ACS Biomater Sci Eng (2016) 0.76
Immunomodulatory effects of coated gold nanoparticles in LPS-stimulated in vitro and in vivo murine model systems. Chem (2016) 0.75
Core/shell protein-reactive nanogels via a combination of RAFT polymerization and vinyl sulfone postmodification. Nanomedicine (Lond) (2016) 0.75
Modulation of protein behavior through light responses of TiO2 nanodots films. Sci Rep (2015) 0.75
Clitocybe nuda Activates Dendritic Cells and Acts as a DNA Vaccine Adjuvant. Evid Based Complement Alternat Med (2013) 0.75
Oral delivery of tumor microparticle vaccines activates NOD2 signaling pathway in ileac epithelium rendering potent antitumor T cell immunity. Oncoimmunology (2017) 0.75
Coordinating antigen cytosolic delivery and danger signaling to program potent cross-priming by micelle-based nanovaccine. Cell Discov (2017) 0.75
Macrophage-derived reactive oxygen species protects against autoimmune priming with a defined polymeric adjuvant. Immunology (2015) 0.75
An Antigen-Presenting and Apoptosis-Inducing Polymer Microparticle Prolongs Alloskin Graft Survival by Selectively and Markedly Depleting Alloreactive CD8(+) T Cells. Front Immunol (2017) 0.75
Chemokine programming dendritic cell antigen response: part II - programming antigen presentation to T lymphocytes by partially maintaining immature dendritic cell phenotype. Immunology (2013) 0.75
Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy. Int J Nanomedicine (2016) 0.75
Polyelectrolyte-Enrobed Cancer Cells in View of Personalized Immune-Therapy. Adv Sci (Weinh) (2017) 0.75
Investigative and clinical applications of synthetic immune synapses. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2012) 0.75
Detection of fluorescent nanoparticle interactions with primary immune cell subpopulations by flow cytometry. J Vis Exp (2014) 0.75
Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine. Sci Rep (2017) 0.75
Developments in high-yield system expressed vaccines and immunotherapy. Recent Pat Biotechnol (2010) 0.75
Mapping Uncertainties in the Upstream: The Case of PLGA Nanoparticles in Salmon Vaccines. Nanoethics (2011) 0.75
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature (2001) 25.15
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16
Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science (2008) 16.54
Regulated portals of entry into the cell. Nature (2003) 15.33
Three-dimensional segregation of supramolecular activation clusters in T cells. Nature (1998) 14.14
Differential antigen processing by dendritic cell subsets in vivo. Science (2007) 8.42
Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A (2006) 6.62
Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol (2005) 5.97
Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature (2006) 5.54
Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity (2003) 5.52
Mucosal immunity and vaccines. Nat Med (2005) 5.44
CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol (2008) 5.35
The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature (1995) 5.13
Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol (2004) 5.13
Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol (2002) 5.08
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater (2008) 4.81
The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur J Immunol (2008) 4.72
Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol (2005) 4.59
The complement system in regulation of adaptive immunity. Nat Immunol (2004) 4.58
Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem (2007) 4.56
Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol (2006) 4.55
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science (1996) 4.35
MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat Immunol (2009) 4.28
Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol (2007) 3.99
Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev (2004) 3.98
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A (2007) 3.94
Altered TCR signaling from geometrically repatterned immunological synapses. Science (2005) 3.94
Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol (2007) 3.75
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev (2008) 3.41
The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity (2007) 3.28
Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J Immunol (2007) 3.17
On regulation of phagosome maturation and antigen presentation. Nat Immunol (2006) 3.11
Barrier properties of mucus. Adv Drug Deliv Rev (2008) 2.84
The physiology of the lymphatic system. Adv Drug Deliv Rev (2001) 2.72
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur J Immunol (2004) 2.48
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci U S A (2009) 2.42
CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med (2007) 2.39
Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. Angew Chem Int Ed Engl (2008) 2.38
Dendrimers and dendritic polymers in drug delivery. Drug Discov Today (2005) 2.37
T-cell regulation: with complements from innate immunity. Nat Rev Immunol (2006) 2.27
Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J Pharm Sci (1994) 2.07
Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood (2003) 2.05
Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater (2004) 2.03
Infection-mimicking materials to program dendritic cells in situ. Nat Mater (2009) 2.00
Oxidation-responsive polymeric vesicles. Nat Mater (2004) 1.82
The microanatomy of T-cell responses. Immunol Rev (2008) 1.82
Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. EMBO J (2006) 1.72
Macrophage complement receptors and pathogen clearance. Cell Microbiol (2007) 1.65
Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. Nano Lett (2007) 1.63
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. J Clin Invest (2008) 1.59
Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. J Control Release (2000) 1.58
Immunological synapse arrays: patterned protein surfaces that modulate immunological synapse structure formation in T cells. Proc Natl Acad Sci U S A (2006) 1.56
Duration, combination and timing: the signal integration model of dendritic cell activation. Trends Immunol (2007) 1.55
PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery. Biomacromolecules (2007) 1.49
Complement activation and inflammation triggered by model biomaterial surfaces. J Biomed Mater Res (1998) 1.32
Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. Bioconjug Chem (2000) 1.32
Fully acid-degradable biocompatible polyacetal microparticles for drug delivery. Bioconjug Chem (2008) 1.28
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine (2008) 1.26
Virus-like particles as a vaccine delivery system: myths and facts. Hum Vaccin (2008) 1.22
Extracellular barriers in respiratory gene therapy. Adv Drug Deliv Rev (2008) 1.22
In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles. Proc Natl Acad Sci U S A (2005) 1.22
Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity. J Immunol (2008) 1.22
Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity. Vaccine (2008) 1.17
Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice. Vaccine (2004) 1.17
Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes. J Immunother (2009) 1.16
Multiblock reducible copolypeptides containing histidine-rich and nuclear localization sequences for gene delivery. Bioconjug Chem (2006) 1.14
Pattern-recognition receptor signaling initiated from extracellular, membrane, and cytoplasmic space. Mol Cells (2007) 1.14
Directed cell migration via chemoattractants released from degradable microspheres. Biomaterials (2005) 1.11
Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo. Eur J Immunol (2008) 1.10
Antigen delivery with poly(propylacrylic acid) conjugation enhances MHC-1 presentation and T-cell activation. Bioconjug Chem (2009) 1.06
The stimulation of CD8+ T cells by dendritic cells pulsed with polyketal microparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid). Biomaterials (2008) 1.03
Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy. Biomaterials (2008) 1.02
PEG-b-PPS diblock copolymer aggregates for hydrophobic drug solubilization and release: cyclosporin A as an example. Mol Pharm (2008) 1.02
Enhanced cell penetration of acid-degradable particles functionalized with cell-penetrating peptides. Bioconjug Chem (2008) 1.00
Cytosolic delivery mediated via electrostatic surface binding of protein, virus, or siRNA cargos to pH-responsive core-shell gel particles. Biomacromolecules (2009) 0.98
Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells. Mol Ther (2008) 0.97
Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles. Adv Drug Deliv Rev (2009) 0.95
T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size. Bioconjug Chem (2009) 0.94
Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery. Vaccine (2004) 0.94
Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus. Gene Ther (2002) 0.93
Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors. Acta Biomater (2008) 0.92
The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles. J Pharm Sci (2008) 0.92
Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems. Curr Drug Deliv (2006) 0.90
pH-responsive shielding of non-viral gene vectors. Expert Opin Drug Deliv (2006) 0.88
Salmonella-like bioadhesive nanoparticles. J Control Release (2005) 0.88
Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model. Vaccine (2004) 0.86
Toll-like receptor 7 agonists and skin. Drug News Perspect (2008) 0.86
Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response. PLoS One (2007) 0.86
The covalent binding reaction of complement component C3. J Immunol (1998) 0.85
Amplification of the antibody response by C3b complexed to antigen through an ester link. J Immunol (1999) 0.84
Complement activation by PEO-grafted glass surfaces. J Biomed Mater Res (1999) 0.83
Development of an adjuvant-active nonionic block copolymer for use in oil-free subunit vaccines formulations. Vaccine (1997) 0.81
Specific interactions of polystyrene biomaterials with factor D of human complement. Biomaterials (1993) 0.77
Interfacial reactivity of block copolymers: understanding the amphiphile-to-hydrophile transition. Langmuir (2005) 0.77
Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol (2006) 8.81
Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol (2005) 4.59
Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol (2007) 3.75
Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst (2005) 3.58
Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science (2010) 3.08
Mechanobiology in the third dimension. Ann Biomed Eng (2005) 2.89
Interstitial flow as a guide for lymphangiogenesis. Circ Res (2003) 2.82
Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell (2007) 2.48
Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin. Circ Res (2005) 2.08
Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J Cell Sci (2005) 2.07
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release (2006) 2.05
Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol (2006) 1.85
Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc Res (2006) 1.70
Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng (2009) 1.69
Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev (2012) 1.64
Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc Natl Acad Sci U S A (2005) 1.59
Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J Clin Invest (2013) 1.57
VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep (2012) 1.51
Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. FASEB J (2007) 1.50
An agarose-based microfluidic platform with a gradient buffer for 3D chemotaxis studies. Biomed Microdevices (2009) 1.48
Engineering synthetic vaccines using cues from natural immunity. Nat Mater (2013) 1.48
Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. Am J Pathol (2009) 1.47
A driving force for change: interstitial flow as a morphoregulator. Trends Cell Biol (2006) 1.43
Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res (2009) 1.41
Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. Circ Res (2010) 1.41
Bronchial epithelial compression regulates MAP kinase signaling and HB-EGF-like growth factor expression. Am J Physiol Lung Cell Mol Physiol (2002) 1.40
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci U S A (2011) 1.39
Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation. Vaccine (2010) 1.37
Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Proc Natl Acad Sci U S A (2011) 1.36
Characterization of lymphangiogenesis in a model of adult skin regeneration. Am J Physiol Heart Circ Physiol (2006) 1.35
Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc Res (2004) 1.35
Fluid flow regulates stromal cell organization and CCL21 expression in a tissue-engineered lymph node microenvironment. J Immunol (2009) 1.30
Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber. Integr Biol (Camb) (2011) 1.28
Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science (2014) 1.27
Fibroblast alignment under interstitial fluid flow using a novel 3-D tissue culture model. Am J Physiol Heart Circ Physiol (2003) 1.27
An ultra-thin PDMS membrane as a bio/micro-nano interface: fabrication and characterization. Biomed Microdevices (2007) 1.23
Regulation of lymphatic capillary regeneration by interstitial flow in skin. Am J Physiol Heart Circ Physiol (2006) 1.22
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose. Proc Natl Acad Sci U S A (2013) 1.20
Dermal collagen and lipid deposition correlate with tissue swelling and hydraulic conductivity in murine primary lymphedema. Am J Pathol (2010) 1.18
Tumor cell invasion is promoted by interstitial flow-induced matrix priming by stromal fibroblasts. Cancer Res (2011) 1.16
Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage. J Immunol (2012) 1.15
Autologous morphogen gradients by subtle interstitial flow and matrix interactions. Biophys J (2006) 1.13
Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response. Biomaterials (2013) 1.13
Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice. PLoS One (2013) 1.12
An in vitro airway wall model of remodeling. Am J Physiol Lung Cell Mol Physiol (2003) 1.11
Physiological 3D tissue model of the airway wall and mucosa. Nat Protoc (2006) 1.10
Bond-detach lithography: a method for micro/nanolithography by precision PDMS patterning. Small (2007) 1.10
Effects of extracellular fiber architecture on cell membrane shear stress in a 3D fibrous matrix. J Biomech (2006) 1.10
Emerging roles of lymphatic endothelium in regulating adaptive immunity. J Clin Invest (2014) 1.09
Extracellular matrix remodeling by dynamic strain in a three-dimensional tissue-engineered human airway wall model. Am J Respir Cell Mol Biol (2006) 1.09
Cells in 3D matrices under interstitial flow: effects of extracellular matrix alignment on cell shear stress and drag forces. J Biomech (2009) 1.09
Cooperative roles of SDF-1α and EGF gradients on tumor cell migration revealed by a robust 3D microfluidic model. PLoS One (2013) 1.07
Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis. FASEB J (2012) 1.07
Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes. Cancer Immunol Res (2014) 1.06
Engineered blood and lymphatic capillaries in 3-D VEGF-fibrin-collagen matrices with interstitial flow. Biotechnol Bioeng (2007) 1.06
The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion. Am J Physiol Cell Physiol (2008) 1.04
Mechanisms of interstitial flow-induced remodeling of fibroblast-collagen cultures. Ann Biomed Eng (2006) 1.02
A multichamber fluidic device for 3D cultures under interstitial flow with live imaging: development, characterization, and applications. Biotechnol Bioeng (2010) 1.01
A sensitive in vivo model for quantifying interstitial convective transport of injected macromolecules and nanoparticles. J Appl Physiol (1985) (2006) 1.01
Regulation of tumor invasion by interstitial fluid flow. Phys Biol (2011) 1.01
Intravital immunofluorescence for visualizing the microcirculatory and immune microenvironments in the mouse ear dermis. PLoS One (2013) 0.98
Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Vaccine (2011) 0.98
Engineering complement activation on polypropylene sulfide vaccine nanoparticles. Biomaterials (2010) 0.98
Role of lymphatic vessels in tumor immunity: passive conduits or active participants? J Mammary Gland Biol Neoplasia (2010) 0.97
A tissue-engineered model of the intestinal lacteal for evaluating lipid transport by lymphatics. Biotechnol Bioeng (2009) 0.96
Nano-sized drug-loaded micelles deliver payload to lymph node immune cells and prolong allograft survival. J Control Release (2011) 0.96
Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages. Int J Nanomedicine (2012) 0.95
Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes. Biomaterials (2012) 0.95
Normal dendritic cell mobilization to lymph nodes under conditions of severe lymphatic hypoplasia. J Immunol (2013) 0.93
PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration. Vaccine (2010) 0.91
In vitro models of inhalation toxicity and disease. The report of a FRAME workshop. Altern Lab Anim (2009) 0.91
Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism. Cancer Res (2012) 0.90
3D collagen cultures under well-defined dynamic strain: a novel strain device with a porous elastomeric support. Biotechnol Bioeng (2009) 0.87
Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles. Biomaterials (2013) 0.86
Polymer micelles with pyridyl disulfide-coupled antigen travel through lymphatics and show enhanced cellular responses following immunization. Acta Biomater (2012) 0.85
PEG-b-PPS-b-PEI micelles and PEG-b-PPS/PEG-b-PPS-b-PEI mixed micelles as non-viral vectors for plasmid DNA: tumor immunotoxicity in B16F10 melanoma. Biomaterials (2011) 0.84
Modeling tumor microenvironments in vitro. J Biomech Eng (2014) 0.84
Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis. Angiogenesis (2013) 0.84
Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization. Vaccine (2012) 0.83
ADAM17 silencing in mouse colon carcinoma cells: the effect on tumoricidal cytokines and angiogenesis. PLoS One (2012) 0.83
Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest (2016) 0.82
The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165. Biomaterials (2013) 0.82
Microarray analysis of VEGF-C responsive genes in human lymphatic endothelial cells. Lymphat Res Biol (2005) 0.80
Multiscale modeling of lymphatic drainage from tissues using homogenization theory. J Biomech (2011) 0.80
Effects of dynamic compression on lentiviral transduction in an in vitro airway wall model. Am J Physiol Lung Cell Mol Physiol (2007) 0.79
Hematogenous metastasis: roles of CD44v and alternative sialofucosylated selectin ligands. Adv Exp Med Biol (2011) 0.78
VEGFR-3 neutralization inhibits ovarian lymphangiogenesis, follicle maturation, and murine pregnancy. Am J Pathol (2013) 0.77
Inflammatory lymphangiogenesis in postpartum breast tissue remodeling. J Clin Invest (2014) 0.76
6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice. Cancer Immunol Immunother (2015) 0.76
Corrigendum: Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation. Nat Cell Biol (2015) 0.75